Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Clinical trial NCT06276491 · RECRUITING

Trial details

NCT number: NCT06276491
Sponsor: Xencor, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Endometrial Cancer Germ Cell Tumor Testicular Germ Cell Tumor Ovarian Germ Cell Tumor

Start date: 2024-04-04
Primary completion: 2027-12-01
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.